Arkolith/Insider Trading/TENX/Form 4

Giordano Christopher Thomas

CEO, DirectorTENAX THERAPEUTICS, INC. (TENX) · full profile →Form 4 · filed Nov 20, 2025
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2025Buy(P)538$7.59$4K3K
Nov 19, 2025Buy(P)455$7.51$3K2K
Nov 18, 2025Buy(P)2K$7.75$12K2K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001871714-25-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML